Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Total Liabilities (2016 - 2025)

National Research's Total Liabilities history spans 16 years, with the latest figure at $120.9 million for Q4 2025.

  • For Q4 2025, Total Liabilities rose 19.39% year-over-year to $120.9 million; the TTM value through Dec 2025 reached $120.9 million, up 19.39%, while the annual FY2025 figure was $120.9 million, 19.39% up from the prior year.
  • Total Liabilities for Q4 2025 was $120.9 million at National Research, roughly flat from $121.4 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $121.4 million in Q3 2025 and bottomed at $55.9 million in Q2 2023.
  • The 5-year median for Total Liabilities is $73.6 million (2021), against an average of $82.0 million.
  • The largest annual shift saw Total Liabilities fell 19.08% in 2022 before it soared 56.07% in 2024.
  • A 5-year view of Total Liabilities shows it stood at $72.2 million in 2021, then fell by 19.08% to $58.4 million in 2022, then grew by 25.77% to $73.5 million in 2023, then soared by 37.8% to $101.3 million in 2024, then rose by 19.39% to $120.9 million in 2025.
  • Per Business Quant, the three most recent readings for NRC's Total Liabilities are $120.9 million (Q4 2025), $121.4 million (Q3 2025), and $120.1 million (Q2 2025).